Trial Profile
Pharmacokinetic study of drinkable preparation of theracurmin (curcumin) in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Curcumin (Primary)
- Indications Cancer; Chronic obstructive pulmonary disease; Cognition disorders; Left ventricular hypertrophy; Pancreatic cancer
- Focus Pharmacokinetics
- 09 Dec 2015 New trial record